<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Kallewaard, Nicole L.</dc:creator>
  <dc:creator>Corti, Davide</dc:creator>
  <dc:creator>Collins, Patrick J.</dc:creator>
  <dc:creator>Neu, Ursula</dc:creator>
  <dc:creator>McAuliffe, Josephine M.</dc:creator>
  <dc:creator>Benjamin, Ebony</dc:creator>
  <dc:creator>Wachter-Rosati, Leslie</dc:creator>
  <dc:creator>Palmer-Hill, Frances J.</dc:creator>
  <dc:creator>Yuan, Andy Q.</dc:creator>
  <dc:creator>Walker, Philip A.</dc:creator>
  <dc:creator>Vorlaender, Matthias K.</dc:creator>
  <dc:creator>Bianchi, Siro</dc:creator>
  <dc:creator>Guarino, Barbara</dc:creator>
  <dc:creator>De Marco, Anna</dc:creator>
  <dc:creator>Vanzetta, Fabrizia</dc:creator>
  <dc:creator>Agatic, Gloria</dc:creator>
  <dc:creator>Foglierini, Mathilde</dc:creator>
  <dc:creator>Pinna, Debora</dc:creator>
  <dc:creator>Fernandez-Rodriguez, Blanca</dc:creator>
  <dc:creator>Fruehwirth, Alexander</dc:creator>
  <dc:creator>Silacci, Chiara</dc:creator>
  <dc:creator>Ogrodowicz, Roksana W.</dc:creator>
  <dc:creator>Martin, Stephen R.</dc:creator>
  <dc:creator>Sallusto, Federica</dc:creator>
  <dc:creator>Suzich, JoAnn A.</dc:creator>
  <dc:creator>Lanzavecchia, Antonio</dc:creator>
  <dc:creator>Zhu, Qing</dc:creator>
  <dc:creator>Gamblin, Steven J.</dc:creator>
  <dc:creator>Skehel, John J.</dc:creator>
  <dc:date>2016-07-21</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Influenza virus remains a threat because of its ability to evade vaccine-induced immune responses  due to antigenic drift. Here, we describe the isolation, evolution, and structure of a broad-spectrum  human monoclonal antibody (mAb), MEDI8852, effectively reacting with all influenza A  hemagglutinin (HA) subtypes. MEDI8852 uses the heavy-chain VH6-1 gene and has higher potency  and breadth when compared to other anti-stem antibodies. MEDI8852 is effective in mice and ferrets  with a therapeutic window superior to that of oseltamivir. Crystallographic analysis of Fab alone or in  complex with H5 or H7 HA proteins reveals that MEDI8852 binds through a coordinated movement  of CDRs to a highly conserved epitope encompassing a hydrophobic groove in the fusion domain  and a large portion of the fusion peptide, distinguishing it from other structurally characterized cross- reactive antibodies. The unprecedented breadth and potency of neutralization by MEDI8852 support  its development as immunotherapy for influenza virus-infected humans.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://n2t.net/ark:/12658/srd1319400</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/319400</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319400/files/Foglierini_2020_cell.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cell.2016.05.073</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319400</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Cell. - 2016, vol. 166, no. 3, p. 596-608</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Structure and function analysis of an antibody recognizing all influenza A subtypes</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
